Chiral Technologies, Inc. | Authors

This application note demonstrates how the use of DCM in particular had a dramatic effect on the separation and afforded conditions that could be further adapted to a preparative scale application.

This application note shares new chiral separations for (±)-catechin and several Daicel immobilized chiral stationary phases. It also highlights elution order reversals.

This application note shares new chiral separations for the anti-viral, COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials.

See chiral separations for anti-viral COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials, on Daicel chiral and achiral columns.

Daicel’s CHIRALPAK® IJ gives access to an expanded range of solvents, which yields new separations not previously achievable on the coated CHIRALCEL® OJ.